Hyperlipidaemia in diabetes: are there particular considerations for next generation therapies?
Béliard S, Mourre F, Valéro R
Diabetologia. Pub. online 20 Feb 2024.
Leggi
Non-pharmacological interventions to improve cardiovascular risk factors in people with diabetic foot disease: A systematic review and meta-analysis
Highton P, Almaqhawi A, Oroko M, et al.
Diabetes Research and Clinical Practice. Pub. online 24 Feb 2024.
Leggi
Effect of low dose semaglutide in people with type 1 diabetes and excess weight
Grassi BA, Onetto MT, Sánchez C, Tapia N, Mena F
Diabetes Research and Clinical Practice. Pub. online 24 Feb 2024.
Leggi
Randomized trial of assisted hybrid closed-loop therapy versus sensor-augmented pump therapy in pregnancy
Polsky S, Buschur E, Dungan K, et al.
Diabetes Technol Ther. Pub. online 22 Feb 2024.
Leggi
Safety, tolerability and immunogenicity of PRV 101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double blind randomised placebo controlled Phase I trial
Hyöty H, Kääriäinen S, Laiho JE, t al.
Diabetologia. Pub. online 19 Feb 2024.
Leggi
Phenotype based targeted treatment of SGLT2 inhibitors and GLP 1 receptor agonists in type 2 diabetes
Cardoso P, Young KG, Nair ATN, et al.
Diabetologia. Pub. online 22 Feb 2024.
Leggi
Continuous glucose monitoring–based metrics and hypoglycemia duration in insulin-experienced individuals with long-standing type 2 diabetes switched from a daily basal insulin to once-weekly insulin icodec: post hoc analysis of ONWARDS 2 and ONWARDS 4
Bajaj HS, Ásbjörnsdóttir B, Carstensen L, et al.
Diabetes Care. 2024:dc232136
Leggi
Gli Highlights dal XXIV Congresso Nazionale AMD
Highlights #1 Highlights #2 Highlights #3 Highlights #4
Leggi
